{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/kodiak-sciences-announces-first-patients-enrolled-in-global-phase-3-alto-trial-of-ksi-501-in-patients-with-diabetic-macular-edema-302847506.html", "message": "News view counter 874146 successfully enlarged"}